DERMATA THERAPEUTICS, INC. Current Liabilities
DERMATA THERAPEUTICS, INC. (DRMA) had Current Liabilities of $1.52 million as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2022-03-28
- 2021-12-31: Liabilities, Current $1.52M.
- 2021-09-30: Liabilities, Current $1.20M.
- 2021-06-30: Liabilities, Current $1.64M.
- 2020-12-31: Liabilities, Current $3.78M.
| Period end | Liabilities, Current |
|---|---|
| 2021-12-31 | $1.52M 10-K · filed 2022-03-28 |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.64M 10-Q · filed 2021-09-27 |
| 2020-12-31 | $3.78M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |